These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
637 related articles for article (PubMed ID: 8710158)
21. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. Dittrich E; Schillinger M; Sunder-Plassmann G; Hörl WH; Vychytil A Perit Dial Int; 2002; 22(1):60-6. PubMed ID: 11929146 [TBL] [Abstract][Full Text] [Related]
22. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients. Kaneko Y; Miyazaki S; Hirasawa Y; Gejyo F; Suzuki M Kidney Int; 2003 Mar; 63(3):1086-93. PubMed ID: 12631092 [TBL] [Abstract][Full Text] [Related]
23. [Zinc protoporphyrin (ZPP) in diagnosis of anemia]. Paszkowska M; Jezyńska A; Król M; Rokicka-Piotrowicz M; Kuratowska Z Pol Arch Med Wewn; 1997 Dec; 98(12):520-6. PubMed ID: 9640080 [TBL] [Abstract][Full Text] [Related]
24. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin. Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076 [TBL] [Abstract][Full Text] [Related]
25. Erythropoietin therapy in pre-dialysis patients with chronic renal failure: lack of need for parenteral iron. Trivedi HS; Brooks BJ Am J Nephrol; 2003; 23(2):78-85. PubMed ID: 12481145 [TBL] [Abstract][Full Text] [Related]
26. An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin. Markowitz GS; Kahn GA; Feingold RE; Coco M; Lynn RI Clin Nephrol; 1997 Jul; 48(1):34-40. PubMed ID: 9247776 [TBL] [Abstract][Full Text] [Related]
27. A comparison between the soluble transferrin receptor, transferrin saturation and serum ferritin as markers of iron state in hemodialysis patients. Beerenhout C; Bekers O; Kooman JP; van der Sande FM; Leunissen KM Nephron; 2002 Sep; 92(1):32-5. PubMed ID: 12187081 [TBL] [Abstract][Full Text] [Related]
28. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project. Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035 [TBL] [Abstract][Full Text] [Related]
29. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients. Daschner M; Mehls O; Schaefer F Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327 [TBL] [Abstract][Full Text] [Related]
30. Diagnosis of iron deficiency in chronic renal failure. Fernández-Rodríguez AM; Guindeo-Casasús MC; Molero-Labarta T; Domínguez-Cabrera C; Hortal-Casc n L; Pérez-Borges P; Vega-Díaz N; Saavedra-Santana P; Palop-Cubillo L Am J Kidney Dis; 1999 Sep; 34(3):508-13. PubMed ID: 10469862 [TBL] [Abstract][Full Text] [Related]
31. Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patients. Sepandj F; Jindal K; West M; Hirsch D Nephrol Dial Transplant; 1996 Feb; 11(2):319-22. PubMed ID: 8671786 [TBL] [Abstract][Full Text] [Related]
32. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894 [TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients. Nissenson AR; Berns JS; Sakiewicz P; Ghaddar S; Moore GM; Schleicher RB; Seligman PA Am J Kidney Dis; 2003 Aug; 42(2):325-30. PubMed ID: 12900815 [TBL] [Abstract][Full Text] [Related]
34. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Fishbane S; Frei GL; Maesaka J Am J Kidney Dis; 1995 Jul; 26(1):41-6. PubMed ID: 7611266 [TBL] [Abstract][Full Text] [Related]
35. [Current recommendations for the treatment of iron deficiency anemia]. Schaefer RM; Huch R; Krafft A; Rev Med Suisse; 2007 Apr; 3(105):874-80. PubMed ID: 17514929 [TBL] [Abstract][Full Text] [Related]
36. [Treatment of renal anemia with iron in hemodialysis patients in General Hospital Bjelovar]. Lovcić V; Vujić J; Basić-Jukić N; Janković RI; Kurtović I; Dzapo M; Lovcić P Acta Med Croatica; 2011 Oct; 65 Suppl 3():45-8. PubMed ID: 23120815 [TBL] [Abstract][Full Text] [Related]
37. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels. Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097 [TBL] [Abstract][Full Text] [Related]
38. [Helicobacter pylori does not contribute to iron deficiency in hemodialysis patients]. López T; Almirall J; Calvet X; Quesada M; Sanfeliú I; Segura F; García M Nefrologia; 2006; 26(6):673-8. PubMed ID: 17227244 [TBL] [Abstract][Full Text] [Related]
39. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. Besarab A; Amin N; Ahsan M; Vogel SE; Zazuwa G; Frinak S; Zazra JJ; Anandan JV; Gupta A J Am Soc Nephrol; 2000 Mar; 11(3):530-538. PubMed ID: 10703677 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic utility of zinc protoporphyrin to detect iron deficiency in Kenyan pregnant women. Mwangi MN; Maskey S; Andang o PE; Shinali NK; Roth JM; Trijsburg L; Mwangi AM; Zuilhof H; van Lagen B; Savelkoul HF; Demir AY; Verhoef H BMC Med; 2014 Nov; 12():229. PubMed ID: 25428714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]